Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 8.

Journal Article

Brandao, Mariana ORCID: 0000-0002-1653-3544, Maurer, Christian, Ziegelmann, Patricia Klarmann, Ponde, Noam F., Ferreira, Arlindo ORCID: 0000-0002-1567-9322, Martel, Samuel, Piccart, Martine, de Azambuja, Evandro ORCID: 0000-0001-9501-4509, Debiasi, Marcio and Lambertini, Matteo ORCID: 0000-0003-1797-5296 (2020). Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis. ESMO Open, 5 (4). LONDON: BMJ PUBLISHING GROUP. ISSN 2059-7029

Ferreira, Arlindo R., Ponde, Noam, Lambertini, Matteo, Maurer, Christian, Martel, Samuel, Costa, Luis and De Azambuja, Evandro (2020). Association between pertuzumab (P) induced diarrhea and skin rash and survival outcomes in patients (pts) with HER2-positive metastatic breast cancer enrolled in the CLEOPATRA trial. Cancer Res., 80 (4). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Martel, Samuel, Bruzzone, Marco ORCID: 0000-0002-8821-4542, Ceppi, Marcello ORCID: 0000-0002-8177-8003, Maurer, Christian, Ponde, Noam Falbel, Ferreira, Arlindo R., Viglietti, Giulia, Del Mastro, Lucia ORCID: 0000-0002-9546-5841, Prady, Catherine, de Azambuja, Evandro ORCID: 0000-0001-9501-4509 and Lambertini, Matteo ORCID: 0000-0003-1797-5296 (2018). Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis. Cancer Treat. Rev., 62. S. 123 - 133. OXFORD: ELSEVIER SCI LTD. ISSN 1532-1967

Martel, Samuel, Lambertini, Matteo, Agbor-Tarh, Dominique, Ponde, Noam Falbel, Gombos, Andrea, Paterson, Vicki, Hilbers, Florentine ORCID: 0000-0002-6764-3102, Korde, Larissa, Manukyants, Anna, Dueck, Amylou C., Maurer, Christian, Piccart-Gebhart, Martine J., Moreno-Aspitia, Alvaro, Desmedt, Christine ORCID: 0000-0002-5223-5579, Di Cosimo, Serena and De Azambuja, Evandro (2018). Impact of body mass index (BMI) and weight change after treatment in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Secondary analysis of the ALTTO BIG 2-06 trial. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Martel, Samuel, Maurer, Christian, Lambertini, Matteo ORCID: 0000-0003-1797-5296, Ponde, Noam and De Azambuja, Evandro (2017). Breast cancer treatment-induced cardiotoxicity. Expert Opin. Drug Saf., 16 (9). S. 1021 - 1039. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1744-764X

Maurer, Christian, Ferreira, Arlindo R., Martel, Samuel, Lambertini, Matteo ORCID: 0000-0003-1797-5296, Ponde, Noam, Aftimos, Philippe, de Azambuja, Evandro ORCID: 0000-0001-9501-4509 and Piccart, Martine (2018). Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer. Breast, 39. S. 14 - 19. EDINBURGH: CHURCHILL LIVINGSTONE. ISSN 1532-3080

Poggio, Francesca, Bruzzone, Marco, Ceppi, Marcello, Conte, Benedetta, Martel, Samuel, Maurer, Christian, Tagliamento, Marco ORCID: 0000-0001-7461-023X, Viglietti, Giulia, Del Mastro, Lucia ORCID: 0000-0002-9546-5841, De Azambuja, Evandro and Lambertini, Matteo (2018). PARP inhibitors (PARPi) for the treatment of BRCA-mutated HER2negative (HER2-) metastatic breast cancer (MBC) patients: A systematic review and meta-analysis. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Poggio, Francesca ORCID: 0000-0002-4518-2827, Bruzzone, Marco ORCID: 0000-0002-8821-4542, Ceppi, Marcello ORCID: 0000-0002-8177-8003, Conte, Benedetta, Martel, Samuel, Maurer, Christian, Tagliamento, Marco ORCID: 0000-0001-7461-023X, Viglietti, Giulia, Del Mastro, Lucia ORCID: 0000-0002-9546-5841, de Azambuja, Evandro ORCID: 0000-0001-9501-4509 and Lambertini, Matteo ORCID: 0000-0003-1797-5296 (2018). Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis. ESMO Open, 3 (4). LONDON: BMJ PUBLISHING GROUP. ISSN 2059-7029

This list was generated on Fri Feb 26 03:53:14 2021 CET.